Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: prediction of malignant transformation.

[1]  S. Hirohashi,et al.  Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. , 1991, Human pathology.

[2]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[3]  O. Matsui,et al.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. , 1999, AJR. American journal of roentgenology.

[4]  J. H. Lim,et al.  Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. , 2002, AJR. American journal of roentgenology.

[5]  H. Honda,et al.  Comparison of Test-Injection Method and Fixed-Time Method for Depiction of Hepatocellular Carcinoma Using Dynamic Steady-State Free Precession Magnetic Resonance Imaging , 2004, Journal of computer assisted tomography.

[6]  Y. Maehara,et al.  Significance of the relationship between irregular regeneration and two hepatocarcinogenic pathways: “De novo” and so‐called “dysplastic nodule‐hepatocellular carcinoma” sequence , 2005, Journal of surgical oncology.

[7]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[8]  T. Ichikawa,et al.  Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. , 2007, AJR. American journal of roentgenology.

[9]  M. Cova,et al.  The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis , 2009, European Radiology.

[10]  Masatoshi Kudo,et al.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology , 2009, Journal of Gastroenterology.

[11]  Onofrio A Catalano,et al.  Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  T. Murakami,et al.  Consensus report of the 2nd International Forum for Liver MRI , 2009, European Radiology.

[13]  B. Choi,et al.  Liver Cancer Working Group report. , 2010, Japanese journal of clinical oncology.

[14]  Chien-Jen Chen,et al.  Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–2 , 2010, Gut.

[15]  M. Kudo.  Will Gd-EOB-MRI Change the Diagnostic Algorithm in Hepatocellular Carcinoma? , 2010, Oncology.

[16]  Kuni Ohtomo,et al.  Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. , 2011, European journal of radiology.

[17]  M. Makuuchi,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version , 2011, Digestive Diseases.

[18]  H. Toyoda,et al.  Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI. , 2011, AJR. American journal of roentgenology.

[19]  U. Motosugi,et al.  Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease , 2011, Journal of magnetic resonance imaging : JMRI.